Imaging Probes for Detecting Inflammation in the Mouse Model of ...

2 downloads 0 Views 173KB Size Report
University of Massachusetts Medical School ... Biomedical Engineering, University of Virginia, Charlottesville, VA. Non-invasive imaging of ... potential use of a combination of clinically available imaging modality (MRI) and emerging high-.
University of Massachusetts Medical School

eScholarship@UMMS UMass Center for Clinical and Translational Science 2017 UMass Center for Clinical and Translational Research Retreat Science Research Retreat May 16th, 1:45 PM

Imaging Probes for Detecting Inflammation in the Mouse Model of Type 1 Diabetes Toloo Taghian University of Massachusetts Medical School

Suresh Gupta University of Massachusetts Medical School

Adam J. Dixon University of Virginia See next page for additional authors

Follow this and additional works at: http://escholarship.umassmed.edu/cts_retreat Part of the Nanotechnology Commons, Radiology Commons, and the Translational Medical Research Commons Taghian, Toloo; Gupta, Suresh; Dixon, Adam J.; Zhang, Surong; and Bogdanov, Alexei A., "Imaging Probes for Detecting Inflammation in the Mouse Model of Type 1 Diabetes" (2017). UMass Center for Clinical and Translational Science Research Retreat. 78. http://escholarship.umassmed.edu/cts_retreat/2017/posters/78

This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in UMass Center for Clinical and Translational Science Research Retreat by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected].

Presenter Information

Toloo Taghian, Suresh Gupta, Adam J. Dixon, Surong Zhang, and Alexei A. Bogdanov Keywords

diabetes, nanoparticles, imaging, diagnosis Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.

This poster abstract is available at eScholarship@UMMS: http://escholarship.umassmed.edu/cts_retreat/2017/posters/78

IMAGING PROBES FOR DETECTING INFLAMMATION IN THE MOUSE MODEL OF TYPE 1 DIABETES Toloo Taghian, PhD1, Suresh Gupta, PhD1, Adam J. Dixon, PhD2, Surong Zhang, PhD1, Alexei A. Bogdanov, PhD1 1 Department of Radiology, University of Massachusetts Medical School; 2Department of Biomedical Engineering, University of Virginia, Charlottesville, VA Non-invasive imaging of early signs of inflammation of endocrine pancreas is of importance due to a generally late clinical diagnosis of type 1 diabetes (T1D). Seventy-80% of insulin producing beta-cells could be already lost prior to the onset of clinical symptoms. Therefore, monitoring these early changes including increased vascular permeability of pancreas and activation of pro-inflammatory signaling pathways will aid in early diagnosis and timing of therapy. We have developed and tested superparamagnetic nanoparticles (NPs) with strong photoacoustic signal for detecting potential permeability changes in the pancreas of streptozotocin (STZ)- induced mouse model of T1D. These biocompatible gold/iron-oxide NPs enable application of multimodality photoacoustic (PA) and magnetic resonance (MR) imaging to investigate the extent of NP accumulation in the pancreas. In addition, we have investigated the spatial distribution of nanoparticles in the endocrine and exocrine of pancreas using electron microscopy techniques. Our initial time-dependent histology results demonstrate the influx of macrophages and neutrophils as the first responders to pancreatic damage as well as activation of the NF-ҡB signaling pathway, which plays a central role in the inflammation of the islets. We recorded a significantly stronger PA signal in the pancreas of STZ-treated mice compared to control mice, which indicate higher accumulation of the NPs in mice with chemically induced diabetes. The potential use of a combination of clinically available imaging modality (MRI) and emerging highresolution/high sensitivity PA makes this approach feasible for clinical translation. Furthermore, the safety of these imaging modalities makes them ideal for both initial diagnosis of diabetes in individuals at risk of T1D and for longer term noninvasive monitoring of the response to therapy. Contact: Toloo Taghian University of Massachusetts Medical School [email protected]

Suggest Documents